Translate to...

Researchers ID new target in drive to improve immunotherapy for cancer

Researchers ID new target in drive to improve immunotherapy for cancer

Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced head and neck squamous cell carcinoma, the most common type of head and neck cancer.